Human Kappa (ƙ) & Lambda (λ) Free Light Chain reagents validated for use on the QuidelOrtho VITROS® 5600/XT 7600 Integrated System and VITROS® 4600 Chemistry System
Diazyme’s Free Light Chain Assays utilize a cost effective latex particle enhanced immunoturbidimetric methodology that provides accurate, reliable testing across the full analytical range. Both assays display excellent precision at the low end while its liquid stable format requires no reagent preparation saving time and reducing sample handling.
The measurement of Kappa FLC in combination with Lambda FLC aids in the diagnosis of plasma cell disorders such as multiple myeloma, lymphocytic neoplasms, Waldenström’s macroglobulinemia, amyloid light-chain (AL) amyloidosis, light chain deposition disease and connective tissue diseases such as systemic lupus erythematosus.1-5
Human Kappa (ƙ) & Lambda (λ) Free Light Chain
- To consolidate testing both assays can be run on the VITROS® 5600 System and VITROS® 4600 System; eliminating the need for standalone systems
- Fast test results for a rapid turnaround time
- Reduce waste and operational expenses with the reagents extended on-board stability of up to four weeks (30 days)
- Formatted liquid reagents ready-to-use, requiring no preparation, saving time and reducing sample handling errors
Now validated for use on QuidelOrtho VITROS® 5600/XT 7600 Integrated System and VITROS® 4600 Chemistry System
| Please order from QuidelOrtho at www.quidelortho.com | |||
Product | Catalog Number | Packaging | Method/Format |
Kappa Kit | DZ169A-K | R1: 1 x 22mL | Latex Enhanced |
Kappa Kit | DZ169A-KY1 | R1: 1 x 22mL | Latex Enhanced |
Lambda Kit | DZ170A-KY1 | R1: 1 x 22mL | Latex Enhanced |
Kappa/Lambda Control | DZ169A-CON | 2 x 3 mL | Liquid Stable |
Kappa:
Ortho-Clinical Diagnostics VITROS 4600 Chemistry System {Diayme Human Kappa Free Light Chain} – CLIA Document Number CR180576
Ortho-Clinical Diagnostics VITROS 5600 Chemistry System {Diayme Human Kappa Free Light Chain} – CLIA Document Number CR180576
Ortho-Clinical Diagnostics VITROS XT 7600 Chemistry System {Diazyme Human Kappa Free Light Chain} – CLIA Document Number CR190266
Lambda:
Ortho-Clinical Diagnostics VITROS 4600 Chemistry System {Diazyme Human Lambda Free Light Chain} – CLIA Document Number CR180576
Ortho-Clinical Diagnostics VITROS 5600 Chemistry System {Diazyme Human Lambda Free Light Chain} – CLIA Document Number CR180576
Ortho-Clinical Diagnostics VITROS XT 7600 Chemistry System {Diazyme Human Lambda Free Light Chain} – CLIA Document Number CR190266
For CLIA decision summary, please click here. Search with provided document number above.
Documents are updated periodically and customers should periodically check to confirm they have the latest version of their technical document.
- International Myeloma Foundation «Understanding Serum Free Light Chain Assays», 2011
- Drayson M, Tang LX, Drew R, Mead GP, Carr-Smith H and Bradwell AR. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood. 2001; 97(9):2900-2.
- Nelson M, Brown RD, Gibson J and Joshua DE. Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma. British Journal of Haematology. 1992; 81(2): 223-30.
- Nakano T, Miyazaki S, Takahashi H, Matsumori A, Maruyama T, Komoda T and Nagata A. Immunochemical quantification of free immunoglobulin light chains from an analytical perspective. Clinical Chemistry Laboratory Medicine. 2006; 44(5): 522-32.
- Bradwell AR, Carr-Smith HD, Mead GP, Harvey TC and Drayson MT. Serum test for assessment of patients with Bence Jones Myeloma. Lancet. 2003; 361: 489-91.